Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesPrevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine
International Journal of Women's Health, 09/17/09
Diaz ML – The prevalence of oncogenic HPV subtypes in cervical cancers has been the most studied, but prevalence has also been established for vaginal and vulvar cancers. Clinical trials demonstrate impressive efficacy in disease prevention as well as excellent safety and tolerability. The role the quadrivalent HPV recombinant vaccine promises to have in the reduction of gynecologic malignancies will depend on various factors, including acceptance and accessibility of the vaccine, duration of immunity, and cross–protection against other oncogenic HPV subtypes. The HPV vaccine’s role in disease reduction will probably be viewed in the context of a strategy that involves continued secondary screening and lifestyle modification to reduce modifiable risk factors, along with widespread vaccination.
Related Articles
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Relevance Score: 100%
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Cancer Prevention Research, 10/08/09
Relevance Score: 99%
Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/21/09
Relevance Score: 98%
HPV: Past, present, and in practice: The Omnia CME Journal
The Journal of Family Practice, 11/02/09
Relevance Score: 97%
FDA approves Cervarix, GlaxoSmithKlines cervical cancer vaccine
GlaxoSmithKline, 10/19/09
Relevance Score: 97%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09
Vaginal Schwannoma in a case with uterine myoma
Annals of Diagnostic Pathology, 12/04/09
Clinical management of uterine sarcomas
The Lancet Oncology, 12/04/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
The legal effects of fetal monitoring guidelines
International Journal of Gynecology & Obstetrics, 12/03/09
A crossover comparison of two types of female condom
International Journal of Gynecology & Obstetrics, 12/03/09
Increased time-to-pregnancy and first trimester Down's syndrome screening
Human Reproduction, 12/03/09
Sponsor
Article Search
Sponsor